BlackRock’s Cellular Biomedicine Group, Inc. CBMG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-878,324
Closed -$16.1M 5313
2020
Q4
$16.1M Buy
878,324
+20,990
+2% +$386K ﹤0.01% 3057
2020
Q3
$15.7M Sell
857,334
-1,256
-0.1% -$23K ﹤0.01% 2929
2020
Q2
$12.9M Buy
858,590
+54,218
+7% +$812K ﹤0.01% 2986
2020
Q1
$12.7M Sell
804,372
-5,710
-0.7% -$90.3K ﹤0.01% 2818
2019
Q4
$13.2M Buy
810,082
+32,720
+4% +$531K ﹤0.01% 3071
2019
Q3
$11.6M Buy
777,362
+27,668
+4% +$411K ﹤0.01% 3102
2019
Q2
$12.4M Buy
749,694
+103,540
+16% +$1.71M ﹤0.01% 3094
2019
Q1
$11.2M Sell
646,154
-11,844
-2% -$205K ﹤0.01% 3042
2018
Q4
$11.6M Buy
657,998
+23,992
+4% +$424K ﹤0.01% 2994
2018
Q3
$11.5M Buy
634,006
+45,154
+8% +$820K ﹤0.01% 3141
2018
Q2
$11.5M Buy
588,852
+499,237
+557% +$9.76M ﹤0.01% 3141
2018
Q1
$1.57M Sell
89,615
-1,717
-2% -$30.1K ﹤0.01% 3711
2017
Q4
$1.03M Sell
91,332
-90
-0.1% -$1.01K ﹤0.01% 3840
2017
Q3
$973K Sell
91,422
-1,086
-1% -$11.6K ﹤0.01% 3850
2017
Q2
$810K Sell
92,508
-511,143
-85% -$4.48M ﹤0.01% 3845
2017
Q1
$7.12M Buy
603,651
+601,936
+35,098% +$7.1M ﹤0.01% 3231
2016
Q4
$22K Sell
1,715
-109
-6% -$1.4K ﹤0.01% 3175
2016
Q3
$27K Buy
1,824
+262
+17% +$3.88K ﹤0.01% 3153
2016
Q2
$19K Buy
1,562
+959
+159% +$11.7K ﹤0.01% 3247
2016
Q1
$12K Buy
603
+361
+149% +$7.18K ﹤0.01% 3038
2015
Q4
$5K Hold
242
﹤0.01% 3145
2015
Q3
$4K Hold
242
﹤0.01% 3072
2015
Q2
$9K Buy
+242
New +$9K ﹤0.01% 2842